The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
UKOF 2018 | Immunotherapy in common solid tumors: an overview
Much of the focus for immunotherapy research is on the cancers for which it works best, such as Hodgkin lymphoma and lung cancer. Elaine Vickers, BMedSc, PhD, from Science Communicated Ltd, Manchester, UK, gave a talk at the UK Oncology Forum (OF) 2018, held in Liverpool, UK, about the current state of immunotherapy research in certain cancer types that are often overlooked in this area: bowel, breast and prostate cancer. In this video, Dr Vickers gives an overview of this talk, discussing current immunotherapy options for these common solid tumor types, and suggesting avenues for future research.
